HEALTH
Shareholders File Suit Against Bristol-Myers: Several lawsuits were filed against Bristol-Myers Squibb Co., charging the drug giant’s executives with misleading the public about the strength of its earnings. However, the company has said it did not make any specific projections about its results. Bristol-Myers stock plunged nearly 10% this week after the company downplayed industry estimates of the company’s sales and earnings for the second quarter and the full year. The company’s stock, which settled at $73.75 a share on Monday, closed Wednesday at $66.375, down 50 cents on the NYSE.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
